Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-109
Closed -$8.24K 1041
2026
Q1
$8.24K Hold
109
﹤0.01% 506
2025
Q4
$8.12K Hold
109
﹤0.01% 475
2025
Q3
$7.36K Hold
109
﹤0.01% 515
2025
Q2
$7.1K Hold
109
﹤0.01% 488
2025
Q1
$6.73K Sell
109
-194
-64% -$12.9K ﹤0.01% 484
2024
Q4
$21.8K Hold
303
0.01% 285
2024
Q3
$24.7K Buy
+303
New +$24.2K 0.02% 273
2023
Q4
Sell
-5
Closed -$347 783
2023
Q3
$347 Hold
5
﹤0.01% 730
2023
Q2
$405 Hold
5
﹤0.01% 714
2023
Q1
$404 Hold
5
﹤0.01% 672
2022
Q4
$374 Hold
5
﹤0.01% 671
2022
Q3
$0 Hold
5
﹤0.01% 885
2022
Q2
$0 Buy
+5
New +$371 ﹤0.01% 892
2021
Q1
Sell
-100
Closed -$7K 754
2020
Q4
$7K Buy
+100
New +$7.06K 0.01% 489

Other funds holding HOLX

Wolff Wiese Magana's HOLX Position: Q2 2026 in Review

Wolff Wiese Magana sold out of Hologic (HOLX) in Q2 2026, closing a stake of 109 shares — an estimated $8.24K sold.

Wolff Wiese Magana first reported a position in HOLX in Q4 2020 and held it in 14 quarters. The position peaked at $24.7K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Wolff Wiese Magana reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Wolff Wiese Magana sold 109 Hologic shares in Q2 2026, an estimated $8.24K.
  • Wolff Wiese Magana first reported a position in Hologic in Q4 2020 and held it in 14 quarters.
  • Wolff Wiese Magana's Hologic position peaked at $24.7K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.